You are here

legislation

With D.C. drug pricing negotiations still up in the air, the 'endgame' could still 'have a bite,' analyst says

With D.C. drug pricing negotiations still up in the air, the 'endgame' could still 'have a bite,' analyst says

Fierce Pharma

Flag link:

Pfizer CEO Bourla asks employees to join the scrum for D.C. drug-pricing fight

Pfizer CEO Bourla asks employees to join the scrum for D.C. drug-pricing fight

Fierce Pharma

Flag link:

Moderate Democrats sink Pelosi’s aggressive drug pricing bill in key committee vote

Moderate Democrats sink Pelosi’s aggressive drug pricing bill in key committee vote

Stat

Flag link:

House moderates rebel against Pelosi drug pricing plan, leaving bill’s fate uncertain

House moderates rebel against Pelosi drug pricing plan, leaving bill’s fate uncertain

Stat

Flag link:

Senate subcommittee advances FY2022 FDA funding bill

Senate subcommittee advances FY2022 FDA funding bill

RAPS.org

Flag link:

How the biopharma industry is helping to pay for the bipartisan infrastructure bill

How the biopharma industry is helping to pay for the bipartisan infrastructure bill

Endpoints

Flag link:

Fight over “pay for delay” heats up in Washington

Fight over “pay for delay” heats up in Washington

MedCity News

Flag link:

As drugmakers spend $6B annually on DTC ads, senators revive bill to include list prices in ads

As drugmakers spend $6B annually on DTC ads, senators revive bill to include list prices in ads

Endpoints

DTC advertising

Flag link:

5 updates on federal drug-pricing legislation

5 updates on federal drug-pricing legislation

Beckers Hospital Review

Flag link:

House Dems to unveil drug pricing measure ahead of Biden package

House Dems to unveil drug pricing measure ahead of Biden package

The Hill

Flag link:

Biopharma ramps up lobbying spend as drug pricing legislation nears

Biopharma ramps up lobbying spend as drug pricing legislation nears

Endpoints

Teva Pharmaceutical

Flag link:

CBO Report Shows Enacting Drug Pricing Legislation Will Result In Fewer New Drugs

CBO Report Shows Enacting Drug Pricing Legislation Will Result In Fewer New Drugs

Forbes

Flag link:

Bills, Bills, Bills: Congress Advances Bills to Address Drug Competition

Bills, Bills, Bills: Congress Advances Bills to Address Drug Competition

FDA Law Blog

Flag link:

How Biden’s infrastructure plan will go after biopharma companies beyond drug pricing

How Biden’s infrastructure plan will go after biopharma companies beyond drug pricing

Endpoints

Flag link:

The top drugs that could be impacted by an obscure provision in the pandemic relief law

The top drugs that could be impacted by an obscure provision in the pandemic relief law

BioPharma Dive

Flag link:

Several states are proposing laws to cut drug prices

Several states are proposing laws to cut drug prices

Beckers Hospital Review

Flag link:

House committee proposes $500M in COVID funding for FDA

House committee proposes $500M in COVID funding for FDA

RAPS.org

Flag link:

Bill to close orphan drug loophole clears House

Bill to close orphan drug loophole clears House

Beckers Hospital Review

Flag link:

5 ways Election Day could impact pharma

5 ways Election Day could impact pharma

Drug Discovery Trends

2020 Presidential election

Flag link:

Policy makers should ‘set their sights higher’ on U.S. drug pricing regulations, researchers say

Policy makers should ‘set their sights higher’ on U.S. drug pricing regulations, researchers say

MedCity News

Flag link:

Pages